Using targeted mouse mutants and pharmacologic inhibition of aCaMKII, we demonstrate that the aCaMKII protein, but not its activation, autophosphorylation or its ability to phosphorylate synapsin I, is required for normal short-term presynaptic plasticity. Furthermore, aCaMKII regulates the number of docked vesicles independent of its ability to be activated. These results indicate that aCaMKII has a nonenzymatic role in short-term presynaptic plasticity at hippocampal CA3-CA1 synapses.
Using targeted mouse mutants and pharmacologic inhibition of aCaMKII, we demonstrate that the aCaMKII protein, but not its activation, autophosphorylation or its ability to phosphorylate synapsin I, is required for normal short-term presynaptic plasticity. Furthermore, aCaMKII regulates the number of docked vesicles independent of its ability to be activated. These results indicate that aCaMKII has a nonenzymatic role in short-term presynaptic plasticity at hippocampal CA3-CA1 synapses.
The a isoform of Ca 2+ /calmodulin-dependent protein kinase II (aCaMKII) was originally identified as synapsin I kinase 1 . Subsequent studies showed that aCaMKII is abundantly associated with presynaptic vesicles by binding to synapsin I (ref. 2) . Together with the observation that aCaMKII is one of the most abundant proteins of the hippocampus 3 , these results suggest that aCaMKII also has a nonenzymatic function, but such a function has not directly been demonstrated yet. Analysis of aCaMKII knockout (KO) mice confirmed a presynaptic role for aCaMKII in short-term presynaptic plasticity 4, 5 , but these experiments did not address whether this role is mediated by aCaMKII as a kinase, as a structural protein, or as both.
To study the enzymatic requirements of aCaMKII in presynaptic plasticity, we used four different lines of aCaMKII mutants. Autophosphorylation at the threonine 286 (T286) and T305/T306 sites was prevented by using aCaMKII-T286A (T286 is mutated to alanine) mice, which lack aCaMKII autonomous (Ca 2+ /CaM independent) activity 6 , and aCaMKII-T305V/T306A (T305 and T306 are mutated to valine and alanine, respectively) mice, which lack aCaMKII inhibitory autophosphorylation 7 . Furthermore, we used aCaMKII-T305D (T305 is mutated to an aspartic acid) mice, in which constitutive autophosphorylation at the T305 site in the Ca 2+ /CaM domain is mimicked, preventing aCaMKII in these mice from becoming activated 7 . The fourth line (aCaMKII-KO) lacks the entire aCaMKII protein 7 (for an overview of all phenotypes see 8 ) .
Because these mutants were backcrossed in C57BL/6, we first tested whether the originally reported long-term potentiation (LTP) deficits (in hybrid 129Sv/C57BL/6 mice) were still present 6, 7, 9 . We confirmed that aCaMKII activation and its subsequent autophosphorylation at T286 are absolute requirements for LTP, but that loss of aCaMKII can partially be compensated for ( Supplementary Fig. 1 online) . In contrast, loss of inhibitory phosphorylation in aCaMKII-T305V/ T306A mice reduced the threshold for LTP induction as reported previously 7 ( Supplementary Fig. 1 ). Western blots of isolated synaptosomes of all the mutants did not reveal changes in the levels of the b, g and d CaMKII isoforms, nor was the amount of calmodulin affected in these mutants ( Supplementary Fig. 2 online) .
We looked at the ability of these mutants to phosphorylate synapsin I at serine 603 (S603, site 3), which is an exclusive CaMKII site. aCaMKII-KO mice showed a marked decrease of synapsin I phosphorylation compared to wild-type mice (P o 0.001, ANOVA, Fig. 1 ), suggesting that none of the other CaMKII isoforms could efficiently compensate for the loss of aCaMKII phosphorylation of synapsin I in vivo. Notably, steady-state levels of phosphorylated synapsin I were not affected in aCaMKII-T286A (P ¼ 0.2) mice and in aCaMKII-T305V/306A mice (P ¼ 0.3), indicating that loss of autonomous activity or self-inhibition does not have a large effect on synapsin I phosphorylation in vivo. In contrast, activation of aCaMKII is an absolute requirement for synapsin I phosphorylation, as S603 phosphorylation in the aCaMKII-T305D mutant was not significantly above background level (P ¼ 0.2; Fig. 1a ). The dominant-negative nature of the aCaMKII-T305D mutation was further illustrated by the fact that this was also the only mutant in which autophosphorylation at both aCaMKII-T286 and bCaMKII-T287 was indistinguishable from background level (both P 4 0.8; Fig. 1b ), further suggesting that aCaMKII is inactive in this mutant. Taken together, these results show that these mutants provide an ideal tool for dissecting the requirements of aCaMKII activation, aCaMKII autophosphorylation and synapsin I S603 phosphorylation in short-term presynaptic plasticity. Previous studies from multiple laboratories 4, 5, 8 , using independently generated targeted deletions of aCaMKII 5, 9 , have demonstrated that the loss of aCaMKII results in enhanced augmentation and decreased synaptic fatigue, which are both measures of presynaptic plasticity. Augmentation is an increase in the evoked postsynaptic response that is observed several seconds after high-frequency afferent stimulation, caused by facilitated exocytosis 10 . We measured augmentation at hippocampal CA3-CA1 synapses using extracellular field recording (Supplementary Methods online). aCaMKII-KO mice showed a striking increase in synaptic augmentation (during 3-11 s: F 4,92 ¼ 13, P o 0.0001, repeated measures ANOVA; Fig. 2 ), confirming that aCaMKII critically regulates this form of presynaptic plasticity 4 . Activation of presynaptic aCaMKII may be important in synaptic augmentation, as transiently elevated presynaptic calcium is thought to be a major factor underlying this process. However, although aCaMKII activity is regulated by autophosphorylation, augmentation was not affected in the T286A and T305V/T306A autophosphorylation-deficient mutants (Fig. 2c) . The lack of a phenotype in these mutants could reflect the short-term nature of this kind of plasticity, and/or the fact that phosphorylation of synapsin I S603 was unaffected in these mutants (Fig. 1) . Unexpectedly however, augmentation was also unaffected in aCaMKII-T305D mutants (P ¼ 0.5, ANOVA; Fig. 2b,c) , where aCaMKII activation was blocked and synapsin I phosphorylation was absent (Fig. 1) . These results strongly suggest that synaptic augmentation does not depend on the ability of aCaMKII to phosphorylate synapsin I, nor on the activation of aCaMKII.
Because activation of both aCaMKII and bCaMKII seem to be impaired in the aCaMKII-T305D mutant (Fig. 1b) , we would expect that a similar result should be obtained if the augmentation experiment is carried out in the presence of the membrane-permeable CaMKII inhibitor . This inhibitor competes with Ca 2+ /calmodulin binding and therefore prevents activation of both aCaMKII and bCaMKII. LTP experiments in the presence of this inhibitor showed that KN-93 was indeed able to block LTP ( Supplementary  Fig. 1 ). In contrast, we observed similar levels of augmentation in the presence of KN-93 or its inactive analog KN-92 (P ¼ 0.5, ANOVA; Fig. 2c ), confirming that CaMKII activation is not required for normal augmentation.
Our biochemical analyses (Fig. 1) indicated that CaMKII activity in the aCaMKII-T305D mutant was reduced to such an extent that phosphorylation of CaMKII substrates was undetectable. If CaMKII activity is indeed not required for augmentation, the potent CaMKII inhibitor AIP-II (autocamtide-2-related inhibitory peptide II) should not affect augmentation either. This inhibitor is 500 times more potent than KN-93, and it is noncompetitive for Ca 2+ /calmodulin and exogenous substrates, thus also blocking basal and autonomously active CaMKII 12 . Efficient penetration was achieved by making use of AIP that was fused to the antennapedia transport peptide, and by preincubating slices for 1 h with AIP (see Supplementary Methods). Indeed, LTP was fully blocked, indicating that the drug was able to penetrate the slice ( Supplementary Fig. 1 ), and notably, Ant-AIP-II showed no discernable effect on synaptic transmission ( Supplementary Fig. 3 online), which makes it suitable for use in these experiments. However, like KN-93, Ant-AIP-II did not affect augmentation (P ¼ 0.1, ANOVA; Fig. 2c ). Taken together, these results indicate that aCaMKII protein, but not aCaMKII activity, is required for normal augmentation.
Previous whole-cell patch-clamp recordings in CA3-restricted aCaMKII-KO mice showed a substantial enhancement of the excitatory postsynaptic current amplitude during repetitive stimulation of CA3-CA1 synapses 5 , suggesting that the fatigue rate of neurotransmitter release is regulated by aCaMKII. Likewise, extracellular field recordings from our global aCaMKII-KO mice also demonstrated reduced synaptic fatigue (Fig. 2d) . The responses to repetitive 10-Hz stimulation reveal the competing processes of facilitation, vesicle depletion and vesicle mobilization 10 . aCaMKII-KO mutants had a similarly shaped curve as wild-type mice; however, there was a significant effect of genotype (F 1,45 ¼ 4.5, P o 0.05) and a significant interaction between genotype and stimulus number (F 99,4455 ¼ 4.5, P o 0.0001). aCaMKII-KO mutants were only significantly different from wild-type mice after 20 stimuli (first 20: F 19,855 ¼ 1.2, P ¼ 0.3; last 80: F 79,3555 ¼ 2.6, P o 0.001), suggesting a differential rate of vesicle depletion and/or mobilization, the cellular processes primarily responsible for the maintenance of excitatory postsynaptic potential (EPSP) amplitude during prolonged stimulation 10 .
To test the aCaMKII autophosphorylation and synapsin I phosphorylation requirements in this presynaptic measure, we repeated this experiment in the aCaMKII point mutants. No significant effect of genotype was observed in either aCaMKII-T286A or aCaMKII-T305V/ T306A autophosphorylation-defective mutants (both P 4 0.3, ANOVA at stimulus number 100; Fig. 2f) . Notably, the depletion rate was also not affected in aCaMKII-T305D mutants (P 4 0.7; Fig. 2e,f) , in which activation of aCaMKII was prevented and phosphorylation of synapsin I was absent. In addition, there was no discernable effect on depression in slices treated with KN-93 or Ant-AIP-II (P ¼ 0.9 and P ¼ 0.7, respectively; Fig. 2f ). Taken together, these data strongly suggest that the aCaMKII protein plays a structural role rather than an enzymatic role, during this form of short-term presynaptic plasticity.
Mechanistically, enhanced synaptic augmentation and reduced synaptic depression could reflect changes in the pool sizes of the synaptic vesicles, in particular the size of the readily releasable pool (RRP). Therefore, we used electron microscopy to measure the number of docked vesicles, a morphological correlate of the RRP 13, 14 . We obtained measurements at the active zone of excitatory synapses on CA1 spines of wild-type, aCaMKII-KO and aCaMKII-T305D mice. Indeed, there was a significant effect of genotype (F 2,41 ¼ 4.7, P o 0.05), with synapses in aCaMKII-KO mice showing a 20% increase in the total number of docked vesicles compared with wild-type (Fisher's PLSD, P o 0.05) or aCaMKII-T305D mice (P o 0.01) (Fig. 3a) . In contrast, no significant difference in the number of docked vesicles was observed between the aCaMKII-T305D mutant and wild-type mice (Fisher's PLSD, P ¼ 0.24). Additional measurements of the number of reserve pool vesicles, active zone length and presynaptic terminal area were similar between the mutants and wild-type mice (all measures P 4 0.2; Supplementary Fig. 4 online) . Thus, the absence of aCaMKII protein results in an increased number of docked vesicles, whereas the loss of aCaMKII activation and synapsin I S603 phosphorylation does not affect vesicle docking.
Together, these results suggest a model in which aCaMKII functions nonenzymatically to limit the size of the RRP, thereby modulating short-term presynaptic plasticity. If the observed increase in the size of EPSPs during repetitive stimulation in aCaMKII-KO mice is indeed mediated by a larger RRP, then presynaptic function should be normal under conditions that minimize depletion of the RRP. Accordingly, we decreased the extracellular calcium concentration, which limits the rate of depletion from the RRP 15 . Decreasing the extracellular calcium concentration from 2.5 to 0.8 mM normalized the responses during 10-Hz stimulation in aCaMKII-KO mice (F 1,31 o 0.0001, P ¼ 1, Fig. 3b ), supporting the idea that aCaMKII limits the available pool of readily-releasable neurotransmitter vesicles.
Taken together, our experiments suggest that synapsin I S603 phosphorylation and aCaMKII activity are not required for shortterm presynaptic plasticity measures such as augmentation and synaptic fatigue during repetitive stimulation. Specifically, we have demonstrated that, at hippocampal CA3-CA1 synapses, aCaMKII functions independently of its kinase activity to modulate short-term presynaptic plasticity by limiting the number of presynaptic docked neurotransmitter vesicles.
Note: Supplementary information is available on the Nature Neuroscience website. 
